Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Gene variation affects prostate issues and hair loss.

Angiopoietin-1 helps hair follicle cells survive and grow, potentially treating hair loss.

Editing the FGF5 gene in sheep increases fine wool growth.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

A new gene causes hairlessness and skin cysts in rats.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Genetic testing can help understand male pattern baldness.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Taurine is important for many body functions and its deficiency can cause health problems.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Finasteride may help treat childhood brain tumors by activating certain genes.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Autophagy is essential for proper skin cell development and function.

α- and γ-catenins help develop fetal skin by 23 weeks.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.